[HTML][HTML] Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting

LJH Borrero, WS El-Deiry - Biochimica et Biophysica Acta (BBA)-Reviews …, 2021 - Elsevier
TP53 is the most commonly mutated gene in human cancer with over 100,000 literature
citations in PubMed. This is a heavily studied pathway in cancer biology and oncology with a …

Mutant p53 in cancer: from molecular mechanism to therapeutic modulation

X Chen, T Zhang, W Su, Z Dou, D Zhao, X Jin… - Cell Death & …, 2022 - nature.com
TP53, a crucial tumor suppressor gene, is the most commonly mutated gene in human
cancers. Aside from losing its tumor suppressor function, mutant p53 (mutp53) often …

Gain-of-function mutant p53 in cancer progression and therapy

C Zhang, J Liu, D Xu, T Zhang, W Hu… - Journal of molecular …, 2020 - academic.oup.com
Abstract p53 is a key tumor suppressor, and loss of p53 function is frequently a prerequisite
for cancer development. The p53 gene is the most frequently mutated gene in human …

RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues

K Yizhak, F Aguet, J Kim, JM Hess, K Kübler, J Grimsby… - Science, 2019 - science.org
INTRODUCTION Cancer genome studies have contributed to the analysis and discovery of
somatic mutations that drive cancer growth. However, studying the genetic makeup of a …

The regulation of ferroptosis by tumor suppressor p53 and its pathway

J Liu, C Zhang, J Wang, W Hu, Z Feng - International journal of molecular …, 2020 - mdpi.com
Tumor suppressor p53 plays a key role in tumor suppression. In addition to tumor
suppression, p53 is also involved in many other biological and pathological processes, such …

Why are there hotspot mutations in the TP53 gene in human cancers?

EH Baugh, H Ke, AJ Levine, RA Bonneau… - Cell Death & …, 2018 - nature.com
The p53 gene contains homozygous mutations in~ 50–60% of human cancers. About 90%
of these mutations encode missense mutant proteins that span~ 190 different codons …

Should mutant TP53 be targeted for cancer therapy?

Z Wang, A Strasser, GL Kelly - Cell Death & Differentiation, 2022 - nature.com
Mutations in the TP53 tumour suppressor gene are found in~ 50% of human cancers [,,,,–].
TP53 functions as a transcription factor that directly regulates the expression of~ 500 genes …

Unravelling mechanisms of p53-mediated tumour suppression

KT Bieging, SS Mello, LD Attardi - Nature Reviews Cancer, 2014 - nature.com
Abstract p53 is a crucial tumour suppressor that responds to diverse stress signals by
orchestrating specific cellular responses, including transient cell cycle arrest, cellular …

Mutant p53 in cancer: new functions and therapeutic opportunities

PAJ Muller, KH Vousden - Cancer cell, 2014 - cell.com
Many different types of cancer show a high incidence of TP53 mutations, leading to the
expression of mutant p53 proteins. There is growing evidence that these mutant p53s have …

Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers

G Bougeard, M Renaux-Petel, JM Flaman… - Journal of Clinical …, 2015 - ascopubs.org
Purpose The aim of the study was to update the description of Li-Fraumeni syndrome (LFS),
a remarkable cancer predisposition characterized by extensive clinical heterogeneity …